Can acipimox reduce serum lipoprotein(a) levels in hemodialyzed patients?
Mavromatidis
K
K
Fitili
C
C
Sombolos
K
K
D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D006435:Renal Dialysis
D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D011719:Pyrazines; C027696:acipimox